Candriam SCA’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-537,601
Closed -$11.5M 686
2025
Q3
$11.5M Buy
+537,601
New +$12.7M 0.06% 255
2024
Q2
Sell
-405,751
Closed -$7.5M 688
2024
Q1
$7.5M Buy
+405,751
New +$10.1M 0.05% 289
2022
Q2
Sell
-230,417
Closed -$5.58M 776
2022
Q1
$5.58M Sell
230,417
-45,143
-16% -$1.09M 0.04% 331
2021
Q4
$6.43M Hold
275,560
0.04% 311
2021
Q3
$4.58M Hold
275,560
0.03% 415
2021
Q2
$6.72M Sell
275,560
-23,328
-8% -$527K 0.05% 350
2021
Q1
$15.3M Hold
298,888
0.13% 179
2020
Q4
$16M Sell
298,888
-10,112
-3% -$502K 0.13% 181
2020
Q3
$12.7M Buy
309,000
+70,000
+29% +$3.02M 0.12% 190
2020
Q2
$11.6M Buy
239,000
+159,000
+199% +$7.63M 0.12% 196
2020
Q1
$3.35M Hold
80,000
0.04% 445
2019
Q4
$3.42M Buy
+80,000
New +$3.48M 0.04% 459
2019
Q1
Sell
-173,700
Closed -$2.81M 789
2018
Q4
$2.81M Buy
173,700
+38,000
+28% +$738K 0.04% 390
2018
Q3
$2.82M Buy
135,700
+3,700
+3% +$58.2K 0.04% 426
2018
Q2
$2.02M Buy
132,000
+55,000
+71% +$981K 0.03% 483
2018
Q1
$1.73M Hold
77,000
0.03% 507
2017
Q4
$2.32M Hold
77,000
0.04% 428
2017
Q3
$2.9M Sell
77,000
-50,000
-39% -$1.63M 0.05% 377
2017
Q2
$3.54M Buy
127,000
+66,000
+108% +$1.97M 0.07% 339
2017
Q1
$2.1M Buy
+61,000
New +$2.15M 0.04% 431
2015
Q4
Sell
-93,200
Closed -$3.08M 557
2015
Q3
$3.08M Sell
93,200
-48,800
-34% -$2.03M 0.08% 273
2015
Q2
$5.95M Sell
142,000
-11,000
-7% -$426K 0.12% 209
2015
Q1
$4.99M Sell
153,000
-12,000
-7% -$412K 0.1% 254
2014
Q4
$5.24M Buy
+165,000
New +$4.68M 0.11% 221

Other funds holding ACAD